Ultrasound-guided Interscalene Block:3mL Ropi Provide Similar Analgesia to 5mL and Less Diaphragmatic Paralysis

Sponsor
Saint George Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04317235
Collaborator
(none)
60
2
36.3

Study Details

Study Description

Brief Summary

Ropivacaine for ultrasound-guided interscalene block: 3mL provide similar analgesia to 5mL with less diaphragmatic paralysis in shoulder arthroscopy surgeries

Condition or Disease Intervention/Treatment Phase
  • Drug: Ropivacaine 0.5% Injectable Solution
N/A

Detailed Description

Ropivacaine for ultrasound-guided interscalene block: 3mL provide similar analgesia to 5mL with less diaphragmatic paralysis in shoulder arthroscopy surgeries with no toxicity and no adverse reaction or complications we targeted under echography each nerve to be blocked alone either to put around all the nerves a big volume

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
Ropivacaine for Ultrasound-guided Interscalene Block: 3mL Provide Similar Analgesia to 5mL With Less Diaphragmatic Paralysis in Shoulder Arthroscopy Surgeries
Actual Study Start Date :
Jan 10, 2016
Actual Primary Completion Date :
Mar 2, 2018
Actual Study Completion Date :
Jan 20, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 3 ml ropivacaine

interscalene block using 3 ml under ultrasound put medication on each nerve

Drug: Ropivacaine 0.5% Injectable Solution
Is to put 3 ml or 5 ml and show the difference
Other Names:
  • interscalene
  • Active Comparator: 5 ml ropivacaine

    interscalene block using 5 ml under ultrasound put medication on each nerve

    Drug: Ropivacaine 0.5% Injectable Solution
    Is to put 3 ml or 5 ml and show the difference
    Other Names:
  • interscalene
  • Outcome Measures

    Primary Outcome Measures

    1. Diaphragmatic paralysis [Up to 48 hours]

      on x ray we look if there is an elevated diaphragm

    2. Pain relief [up to day 2 after operation]

      pain scale 1-10 score 1 no pain and 10 severe pain first by visiting patient before discharge twice and thereafter on the phone

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • ASA1-2
    Exclusion Criteria:
    • ASA3-4 anticoagulant

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Saint George Hospital

    Investigators

    • Principal Investigator: hazem kafrouni, Saint George Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Hazem Kafrouni, Assistant professor, Saint George Hospital
    ClinicalTrials.gov Identifier:
    NCT04317235
    Other Study ID Numbers:
    • SaintgeorgeH
    First Posted:
    Mar 23, 2020
    Last Update Posted:
    Mar 23, 2020
    Last Verified:
    Mar 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 23, 2020